Serotiny is a therapeutic discovery company that designs new genes for next generation cell & gene therapies. We invent therapeutic multi-domain proteins in high-throughput by orchestrating software, mammalian synthetic biology, and therapeutic expertise. At the heart of Serotiny’s technology is a discovery platform involving the close interworking of computationally aided protein design, high-throughput cellular assays, and sophisticated data-driven analytics, which together enable Serotiny to engineer multi-domain proteins for cell therapies, like Chimeric Antigen Receptors used in CAR-T immunotherapies and second-generation Cas9-based gene editing tools, like Base and Prime Editors. Rationally designing proteins for cell & gene therapies requires a different set of constraints and design tools than enzyme or antibody engineering. These therapeutic multi-domain proteins will not be purified, they will be expressed in a human cell, and they will affect the therapeutic phenotype of that cell. Serotiny encodes these constraints into its platform to create a scaled design-build-test-learn process to quickly and efficiently generate therapeutic candidates for next-generation therapies. Serotiny is a multidisciplinary team with expertise including molecular biology, immunology, machine learning, software engineering, data science, and bioinformatics. We’re looking for passionate and creative people to join our team!
View Top Employees from SerotinyWebsite | http://serotiny.com/ |
Employees | 11 (11 on RocketReach) |
Address | 329 Oyster Point Blvd, South San Francisco, California 94080, US |
Technologies |
HTML,
Bootstrap,
Amazon s3
+4 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular Serotiny employee's phone or email?
Brian Buttrick is the Director of Platform of Serotiny.
11 people are employed at Serotiny.
Serotiny is based in South San Francisco, California.